Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?;Une procédure précoce de diagnostic d'acidose lactique liée à la metformine dans un service d'urgences peut-elle réduire la mortalité ?

Therapie

Volumn 71, Issue 6, 2016, Pages 605-612

  Sémely, Damien ^a   Bennett, Emily ^a   Vallejo, Christine ^a   Saint Marcoux, Franck ^a   Merle, Louis ^a   Nouaille, Yves ^a   Lachâtre, Gérard ^a   Laroche, Marie Laure ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Critical care; Diagnosis; Lactic acidosis; Metformin; Pharmacovigilance

Indexed keywords

LACTIC ACID; METFORMIN;

AGED; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE SEVERITY; EARLY DIAGNOSIS; EMERGENCY WARD; FEMALE; HOSPITALIZATION; HUMAN; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LENGTH OF STAY; MALE; METFORMIN ASSOCIATED LACTIC ACID; MORTALITY RATE; MORTALITY RISK; PH; PRIORITY JOURNAL; RISK REDUCTION;

EID: 84978806399     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.1016/j.therap.2016.05.006     Document Type: Article

References (20)

1. [1] Zimmet, P., Alberti, K., Shaw, J., Global and societal implications of the diabetes epidemic. Nature 414:6865 (2001), 782–787.
2. [2] Chen, L., Magliano, D.J., Zimmet, P., The worldwide epidemiology of type 2 diabetes mellitus – present and future perspectives. Nat Rev Endocrinol 8 (2012), 228–236.
3. [3] Pantalone, K.M., Hobbs, T.M., Wells, B.J., Kong, S.X., Kattan, M.W., Bouchard, J., et al. Clinical characteristics, complications, comorbidities and treatment patterns among patients with type 2 diabetes mellitus in a large integrated health system. BMJ Open Diabetes Res Care, 3(1), 2015, e000093.
4. [4] Lalau, J.D., Lactic acidosis induced by metformin: incidence, management and prevention. Drug Saf 33 (2010), 727–740.
5. [5] Lu, W.R., Defilippi, J., Braun, A., Unleash metformin: reconsideration of the contraindication in patients with renal impairment. Ann Pharmacother 47 (2013), 1488–1497.
6. [6] Dykens, J.A., Jamieson, J., Marroquin, L., Nadanaciva, S., Billis, P.A., Will, Y., Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol 233 (2008), 203–210.
7. [7] Dumoulin, M., Quelles sont les recommandations concernant l'acidose lactique associée à la metformine ?. Pharmactuel 40:3 (2007), 161–162 http://www.pharmactuel.com/index.php/pharmactuel/article/viewFile/644/311 [Accessed 23 June 2016 (2 pp.)].
8. [8] Keller, G., Cour, M., Hernu, R., Illinger, J., Robert, D., Argaud, L., Management of metformin-associated lactic acidosis by continuous renal replacement therapy. PLoS One, 6(8), 2011, e23200.
9. [9] Seidowsky, A., Nseir, S., Houdret, N., Fourrier, R., Metformin-associated lactic acidosis: a prognostic and therapeutic study. Crit Care Med 37 (2009), 2191–2196.
10. [10] Laforest, C., Saint-Marcoux, F., Amiel, J.B., Pichon, N., Merle, L., Monitoring of metformin-induced lactic acidosis in a diabetic patient with acute kidney failure and effect of hemodialysis. Int J Clin Pharmacol Ther 51 (2013), 147–151.
11. [11] Arimone Y1, Bidault, I., Dutertre, J.P., Gérardin, M., Guy, C., Haramburu, F., et al. Updating the French method for the causality assessment of adverse drug reactions. Therapie 68:2 (2013), 69–76.
12. [12] Armitage, P., Berry, G., Statistical methods in medical research. 3rd ed., 1994, Blackwell Science Ltd, London.
13. [13] Peters, N., Jay, N., Barraud, D., Cravoisy, A., Nace, L., Bollaert, P.E., et al. Metformin-associated lactic acidosis in an intensive care unit. Crit Care, 12, 2008, R149.
14. [14] Misbin, R.I., Green, L., Stadel, B.V., Gueriguian, J.L., Gubbi, A., Fleming, G.A., Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338 (1998), 265–266.
15. [15] Stades, A.M., Heikens, J.T., Erkelens, D.W., Holleman, F., Hoekstra, J.B., Metformin and lactic acidosis: cause or coincidence? A review of case reports. J Intern Med 255 (2004), 179–187.
16. [16] Biradar, V., Moran, J.L., Peake, S.L., Peter, J.V., Metformin-associated lactic acidosis (MALA): clinical profile and outcomes in patients admitted to the intensive care unit. Crit Care Resusc 12 (2010), 191–195.
17. [17] DeFronzo, R., Fleming, G.A., Chen, K., Bicsak, T.A., Metformin-associated lactic acidosis: current perspectives on causes and risk. Met Clin Exp 65 (2016), 20–29.
18. [18] Lalau, J.D., Race, J.M., Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 20 (1999), 377–384.
19. [19] Misbin, R.I., The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care 27 (2004), 1791–1793.
20. [20] Spiller, H.A., Quadrani, D.A., Toxic effects from metformin exposure. Ann Pharmacother 38 (2004), 776–780.